Spero Therapeutics, Inc. (SPRO)
1.215
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Market Cap : 70.65M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 70.65M |
| August 21, 2026 | 70.94M |
| August 20, 2026 | 70.36M |
| August 19, 2026 | 71.52M |
| August 18, 2026 | 69.78M |
| August 17, 2026 | 69.19M |
| August 14, 2026 | 71.52M |
| August 13, 2026 | 72.10M |
| August 12, 2026 | 69.19M |
| August 11, 2026 | 71.52M |
| August 10, 2026 | 71.52M |
| August 07, 2026 | 72.94M |
| August 06, 2026 | 73.52M |
| August 05, 2026 | 72.94M |
| August 04, 2026 | 71.21M |
| August 03, 2026 | 66.58M |
| July 31, 2026 | 67.73M |
| July 30, 2026 | 69.47M |
| July 29, 2026 | 68.89M |
| July 28, 2026 | 69.18M |
| July 27, 2026 | 68.31M |
| July 24, 2026 | 68.89M |
| July 23, 2026 | 67.15M |
| July 22, 2026 | 73.52M |
| July 21, 2026 | 79.89M |
| Date | Value |
|---|---|
| July 20, 2026 | 83.36M |
| July 17, 2026 | 91.47M |
| July 16, 2026 | 90.89M |
| July 15, 2026 | 98.42M |
| July 14, 2026 | 98.42M |
| July 13, 2026 | 126.20M |
| July 10, 2026 | 121.57M |
| July 09, 2026 | 122.73M |
| July 08, 2026 | 125.62M |
| July 07, 2026 | 125.05M |
| July 06, 2026 | 126.78M |
| July 02, 2026 | 127.36M |
| July 01, 2026 | 128.52M |
| June 30, 2026 | 127.94M |
| June 29, 2026 | 130.83M |
| June 26, 2026 | 130.83M |
| June 25, 2026 | 116.94M |
| June 24, 2026 | 121.57M |
| June 23, 2026 | 124.47M |
| June 22, 2026 | 127.94M |
| June 18, 2026 | 131.99M |
| June 17, 2026 | 122.15M |
| June 16, 2026 | 160.36M |
| June 15, 2026 | 168.46M |
| June 12, 2026 | 164.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 102.93M |
| Fortress Biotech, Inc. | 97.60M |
| Kura Oncology, Inc. | 1.103B |
| Legend Biotech Corp. | 4.058B |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
Market Cap Related Metrics
| PE Ratio | 11.14 |
| PS Ratio | 1.632 |
| Price to Book Value | 1.598 |
| Price to Free Cash Flow | 3.582 |
| Price | 1.215 |
| Earnings Yield | 8.98% |
| Operating PE Ratio | 27.19 |
| Normalized PE Ratio | 10.43 |